NeuroOne receives 180-day extension to regain nasdaq compliance
PositiveFinancial Markets

NeuroOne receives 180-day extension to regain nasdaq compliance
NeuroOne has been granted a 180-day extension to regain compliance with Nasdaq listing requirements. This extension is significant as it provides the company with additional time to meet the necessary standards, which is crucial for maintaining its public listing and investor confidence. The move reflects Nasdaq's recognition of NeuroOne's potential and the importance of its ongoing operations.
— via World Pulse Now AI Editorial System





